BackLakeShore Biopharma Co Ltd. - Warrants (15/03/2028) Overview

LakeShore Biopharma Co Ltd. - Warrants (15/03/2028) Accounts Payable

Track LakeShore Biopharma Co Ltd. - Warrants (15/03/2028)'s accounts payable ($50M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Accounts Payable
$49.55M
↓ 26.89% YoYΔ $-18.22M vs prior year quarter

Peer trimmed avg / median

Loading

LakeShore Biopharma Co Ltd. - Warrants (15/03/2028) Accounts Payable History

Loading

LakeShore Biopharma Co Ltd. - Warrants (15/03/2028) vs. peers: Accounts Payable Comparison

Loading

LakeShore Biopharma Co Ltd. - Warrants (15/03/2028) Accounts Payable Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

LakeShore Biopharma Co Ltd. - Warrants (15/03/2028) (YSBPW) FAQ

As of the most recent data (March 2025), YSBPW shows a accounts payable of $50M. That compares with $68M in the prior-year period — down 26.9% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, YSBPW's accounts payable is now $50M (was $68M) — a 26.9% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether LakeShore Biopharma Co Ltd. - Warrants (15/03/2028) is outperforming or lagging.

Tracking YSBPW's accounts payable over time shows whether LakeShore Biopharma Co Ltd. - Warrants (15/03/2028) is scaling, shrinking, or reshaping that part of the business. The current reading is $50M That compares with $68M in the prior-year period — down 26.9% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this accounts payable page, Stockcircle has LakeShore Biopharma Co Ltd. - Warrants (15/03/2028)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect accounts payable (currently $50M) with ownership activity and broader fundamentals.